What is the difference between a UKRP and an EU Authorised Representative?

A UK Responsible Person (UKRP) is a UK-based entity appointed by a non-UK manufacturer to fulfil MHRA registration and compliance obligations for the Great Britain market. An EU Authorised Representative (EUAR) is an EU-based entity appointed by a non-EU manufacturer to act as the point of contact for EU competent authorities under EU MDR/IVDR. Post-Brexit, manufacturers selling in both markets need both — they cannot be the same entity.

Can the same company act as both UKRP and EU Authorised Representative?

No. A UKRP must be based in the United Kingdom and a EUAR must be established in an EU member state. Since the UK is no longer an EU member, these must be two separate legal entities. However, a manufacturer may appoint two separate services from the same group company if that group has entities in both the UK and the EU.

What legal liability does a UKRP or EU Authorised Representative carry?

Both roles carry significant legal exposure. A UKRP is responsible for ensuring MHRA registration is accurate and current, and may face enforcement action if registered devices are non-compliant. Similarly, an EU Authorised Representative can be held jointly liable with the manufacturer for non-compliant devices under EU MDR Article 11. This is why both roles are typically held by specialist regulatory organisations rather than informal contacts.

Do I need both a UKRP and an EUAR after Brexit?

Yes, if you sell in both the UK (Great Britain) and the EU. Since Brexit, the UK and EU are separate regulatory jurisdictions. A UKRP covers Great Britain, and a EUAR covers the EU. Northern Ireland has its own arrangements under the Windsor Framework — devices sold there may be covered by EU MDR requirements rather than UK MDR in some cases.

Navigating Global Compliance: UK and EU Representation Services for Medical Devices

Non-UK manufacturers placing medical devices on the Great Britain market must appoint a UK Responsible Person (UKRP), and non-EU manufacturers placing devices on the EU market must appoint an EU Authorised Representative (EUAR). Both roles are mandatory legal requirements — not optional compliance enhancements — and both carry significant legal responsibility for regulatory compliance on behalf of the overseas manufacturer.

For medical device manufacturers, expanding into international markets means adapting to diverse regulatory landscapes. Two critical services in this arena are UK Responsible Person (UKRP) Services and EU Authorized Representative Services. These services ensure that companies can successfully navigate the regulatory requirements in the UK and the EU, respectively.

UK Responsible Person (UKRP) Services

In the wake of Brexit, manufacturers wishing to market their products in the United Kingdom must appoint a UK Responsible Person. This essential service involves:

Representation: Acting as the local regulatory point of contact.
Compliance Assurance: Ensuring that all medical device regulations as outlined by the UK authorities are met.
Market Access Facilitation: Streamlining the process of certification and CE marking compliance for the UK market.

By partnering with an experienced provider like Advena Ltd, manufacturers can delegate these responsibilities to experts who are deeply familiar with the latest UK regulations. This not only simplifies compliance but also provides peace of mind as your product navigates the complexities of post-Brexit regulatory requirements.

EU Authorized Representative Services

For companies looking to sell in Europe, the requirement to have an Authorized Representative is a cornerstone of compliance with EU medical device regulations. The EU Authorized Representative is tasked with:

Regulatory Liaison: Acting as the designated contact for European authorities.
Quality Assurance: Supporting manufacturers in meeting the stringent EU regulatory standards and guidelines.
Risk Mitigation: Assisting with rapid responses to compliance issues and audits, ensuring that products remain on the market without interruptions.

Advena Ltd’s approach to EU Authorized Representative Services centers on collaboration and expert guidance. By ensuring that every step is meticulously managed, Advena helps ease the burden of regulatory oversight while opening the door to smoother market entry in the EU.

---

Conclusion

Navigating both UK and EU regulatory requirements can be complex and demanding. Whether you need a UK Responsible Person or an EU Authorized Representative, the expertise provided by industry leaders like Advena ensures you have reliable partners in your journey toward global compliance. With the right representation, your medical devices can confidently meet international standards, allowing you to focus on innovation and growth.